The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

24 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Synthesis and SAR studies of 2-oxoquinoline derivatives as CB2 receptor inverse agonists.EBI
University of Kuopio
Synthesis and CB1 receptor activities of novel arachidonyl alcohol derivatives.EBI
University of Kuopio
N-(3-(4-Hydroxyphenyl)-propenoyl)-amino acid tryptamides as SIRT2 inhibitors.EBI
University of Kuopio
N,N'-Bisbenzylidenebenzene-1,4-diamines and N,N'-Bisbenzylidenenaphthalene-1,4-diamines as Sirtuin Type 2 (SIRT2) Inhibitors.EBI
University of Kuopio
Quantitative structure-activity relationship analysis of inhibitors of the nicotine metabolizing CYP2A6 enzyme.EBI
University of Kuopio
Dicarboxylic acid azacycle l-prolyl-pyrrolidine amides as prolyl oligopeptidase inhibitors and three-dimensional quantitative structure-activity relationship of the enzyme-inhibitor interactions.EBI
University of Kuopio
Predictive three-dimensional quantitative structure-activity relationship of cytochrome P450 1A2 inhibitors.EBI
University of Kuopio
Molecular determinants of steroid inhibition for the mouse constitutive androstane receptor.EBI
University of Kuopio
The synthesis and biological evaluation of para-substituted phenolic N-alkyl carbamates as endocannabinoid hydrolyzing enzyme inhibitors.EBI
University of Kuopio
Glucose promoiety enables glucose transporter mediated brain uptake of ketoprofen and indomethacin prodrugs in rats.EBI
University of Kuopio
N(epsilon)-thioacetyl-lysine-containing tri-, tetra-, and pentapeptides as SIRT1 and SIRT2 inhibitors.EBI
University of Kuopio
Characterization of the binding properties of SIRT2 inhibitors with a N-(3-phenylpropenoyl)-glycine tryptamide backbone.EBI
University of Kuopio
Oxadiazole-carbonylaminothioureas as SIRT1 and SIRT2 inhibitors.EBI
University of Kuopio
Discovering inhibitors of human sirtuin type 2: novel structural scaffolds.EBI
University of Kuopio
Fatty acid amide hydrolase inhibitors from virtual screening of the endocannabinoid system.EBI
University of Kuopio
Synthesis and characterization of the novel fluorescent prolyl oligopeptidase inhibitor 4-fluoresceinthiocarbamoyl-6-aminocaproyl-L-prolyl-2(S)-(hydroxyacetyl)pyrrolidine.EBI
University of Kuopio
An in silico approach to discovering novel inhibitors of human sirtuin type 2.EBI
University of Kuopio
A cyclopent-2-enecarbonyl group mimics proline at the P2 position of prolyl oligopeptidase inhibitors.EBI
University of Kuopio
New prolyl oligopeptidase inhibitors developed from dicarboxylic acid bis(l-prolyl-pyrrolidine) amides.EBI
University of Kuopio
Dicarboxylic acid bis(L-prolyl-pyrrolidine) amides as prolyl oligopeptidase inhibitors.EBI
University of Kuopio
Virtual screening of novel CB2 ligands using a comparative model of the human cannabinoid CB2 receptor.EBI
University of Kuopio
Alpha-methylated derivatives of 2-arachidonoyl glycerol: synthesis, CB1 receptor activity, and enzymatic stability.EBI
University of Kuopio
3D-QSAR studies on cannabinoid CB1 receptor agonists: G-protein activation as biological data.EBI
University of Kuopio
Synthesis and in vitro pharmacology of a series of new chiral histamine H3-receptor ligands: 2-(R and S)-Amino-3-(1H-imidazol-4(5)-yl)propyl ether derivatives.EBI
University of Kuopio